Gemina Laboratories Ltd. (CSE:GLAB)

Canada flag Canada · Delayed Price · Currency is CAD
0.5000
-0.0300 (-5.66%)
Sep 19, 2025, 3:55 PM EDT
-5.66%
Market Cap40.58M
Revenue (ttm)10.88K
Net Income (ttm)-4.01M
Shares Out76.57M
EPS (ttm)-0.05
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,500
Average Volume4,588
Open0.4000
Previous Close0.5300
Day's Range0.4000 - 0.5000
52-Week Range0.2800 - 1.2500
Beta0.23
RSI51.53
Earnings DateAug 29, 2025

About Gemina Laboratories

Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company's products include LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It also develops respiratory syncytial virus and tuberculosis. Gemina Laboratories Ltd. was incorporated in 2017 and is headquartered in Burnaby, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2017
Employees 6
Stock Exchange Canadian Securities Exchange
Ticker Symbol GLAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.